2 In the index

Pramipexole PRAMI

An FDA-approved medication for Parkinson's disease and restless legs syndrome. Human studies strongly support its effectiveness for both, though a notable side effect in some users is a sudden urge toward compulsive behaviors like gambling or shopping.

Also known as Mirapex, (-)-Pramipexole, Mirapexin, Pramipexol, Sifrol, Pramipexolum, U-98528E

Effects Hormonal

Routes Oral

Legal status Prescription drug

WADA Not listed

3D Molecular Structure of C₁₀H₁₇N₃S

Drag to rotate · scroll to zoom

Chemistry

Formula: C10H17N3S
Molar mass: 211.33
CAS: 104632-26-0
PubChem CID: 119570
IUPAC name: (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
InChIKey: FASDKYOPVNHBLU-ZETCQYMHSA-N

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 0.375-1.5 mg/day

Reported range 0.125-4.5 mg/day depending on indication

Route Oral

Frequency 1-3 times daily

Duration Chronic/ongoing (as prescribed)

FDA-approved dopamine agonist (Mirapex) for Parkinson's disease and restless legs syndrome; associated with impulse-control disorder risk (gambling, compulsive behaviors) in some patients.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.